started · updated
Witten Company receives investment from Genaxis
Global accelerator Genaxis has completed an investment in Witten Company, a biomedical skincare startup founded by researchers from the Korea Institute of Science and Technology (KIST). The investment was conducted through a fund jointly established by Genaxis and SS2 Investment.
Witten Company specializes in functional skincare using nano-delivery technologies, such as exosomes and liposomes. The company operates its own brand, ORGANICITY, which offers modular skincare products tailored to specific skin concerns. Its business model integrates raw material research, formulation, manufacturing, and brand management.
Following the investment, Witten Company was selected for the LIPS I program, a matching loan program managed by the Small Enterprise and Market Service. The company plans to use these funds to secure raw materials, expand production capacity, and increase domestic and international sales channels, including markets in Japan, the United States, and Thailand.
Entities
Genaxis · Korea Institute of Science and Technology · ORGANICITY · SS2 Investment · Witten Company